Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Senju describes new calpain inhibitor

April 10, 1997

IDE sought for new technique for glaucoma surgery

April 2, 1997

Selective CB2 receptor agonists prepared by Merck Frosst

April 2, 1997

Ciba Vision launches Ophthalin in U.K.

April 1, 1997

Two dose regimens of latanoprost compared in glaucoma patients

March 25, 1997

Alphagan receives first European approval

March 25, 1997

Alcon prepares carbonic anhydrase inhibitors

March 13, 1997

Positive phase I results for new formulation of lexipafant

March 12, 1997

Gene linked to juvenile macular degeneration cloned

March 7, 1997

Nonsurgical treatment for vitreous hemorrhage enters clinic in the U.S.

March 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...